logo

BLU(Delisted)

BELLUS HealthยทNASDAQ
--
--(--)

BLU Profile

Bellus Health Inc.

A clinical-stage biopharmaceutical company that developing novel therapeutics for refractory chronic cough and other cough hypersensitivity indications

--
04/12/2012
09/05/2019
NASDAQ Stock Exchange
74
12-31
Common stock
275 Armand-Frappier Blvd., Laval, Quebec H7V 4A7, Canada
--
BELLUS Health Inc., was incorporated on April 12, 2012 under the Canadian Business Companies Act. The company is a clinical-stage biopharmaceutical company developing novel therapies for the treatment of chronic cough and other hypersensitivity diseases.